Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
GBIO Generation Bio Co
- Stocks
- Healthcare
- NASDAQ: GBIO
Price (delayed)
$0.3874
Market cap
$25.97M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.08
Enterprise value
$60.5M
Generation Bio is an innovative genetic medicines company focused on creating a new class of non-viral gene therapy to provide durable, redosable treatments for people living with rare and prevalent
Highlights
The gross profit has soared by 146% YoY and by 23% from the previous quarter
GBIO's revenue has surged by 146% year-on-year and by 23% since the previous quarter
The equity has decreased by 44% YoY and by 15% QoQ
Key stats
What are the main financial stats of GBIO
Market
Valuations
Earnings
Shares outstanding
67.04M
Market cap
$25.97M
Enterprise value
$60.5M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.35
Price to sales (P/S)
1.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.46
Revenue
$24.56M
Gross profit
$24.56M
Operating income
-$81.36M
Net income
-$71.93M
EBIT
-$71.93M
EBITDA
-$67.17M
Free cash flow
-$85.73M
Per share
Balance sheet
Liquidity
EPS
-$1.08
EPS diluted
-$1.08
Free cash flow per share
-$1.28
Book value per share
$1.09
Revenue per share
$0.37
TBVPS
$3.01
Total assets
$201.35M
Total liabilities
$128.02M
Debt
$87.58M
Equity
$73.33M
Working capital
$145.52M
Debt to equity
1.19
Current ratio
8.43
Quick ratio
8.22
Net debt/EBITDA
-0.51
Margins
Efficiency
Dividend
EBITDA margin
-273.6%
Gross margin
100%
Net margin
-292.9%
Operating margin
-331.3%
Return on assets
-30.4%
Return on equity
-75.8%
Return on invested capital
-28.4%
Return on capital employed
-39.6%
Return on sales
-292.9%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GBIO stock price
How has the Generation Bio stock price performed over time
Intraday
-2.86%
1 week
5.67%
1 month
-11.13%
1 year
-87.58%
YTD
-63.45%
QTD
-4.35%
Financial performance
How have Generation Bio's revenue and profit performed over time
Revenue
$24.56M
Gross profit
$24.56M
Operating income
-$81.36M
Net income
-$71.93M
Gross margin
100%
Net margin
-292.9%
The gross profit has soared by 146% YoY and by 23% from the previous quarter
GBIO's revenue has surged by 146% year-on-year and by 23% since the previous quarter
Generation Bio's net margin has soared by 83% YoY and by 56% from the previous quarter
GBIO's operating margin has surged by 82% year-on-year and by 54% since the previous quarter
Price vs fundamentals
How does GBIO's price correlate with its fundamentals
Growth
What is Generation Bio's growth rate over time
Valuation
What is Generation Bio stock price valuation
P/E
N/A
P/B
0.35
P/S
1.06
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.46
Generation Bio's EPS has soared by 58% YoY and by 45% from the previous quarter
The P/B is 83% below the 5-year quarterly average of 2.0 and 68% below the last 4 quarters average of 1.1
The equity has decreased by 44% YoY and by 15% QoQ
GBIO's revenue has surged by 146% year-on-year and by 23% since the previous quarter
GBIO's price to sales (P/S) is 85% lower than its last 4 quarters average of 6.9
Efficiency
How efficient is Generation Bio business performance
Generation Bio's ROS has soared by 83% YoY and by 56% from the previous quarter
Generation Bio's ROIC has increased by 45% YoY and by 40% from the previous quarter
The ROA has grown by 41% from the previous quarter and by 35% YoY
Generation Bio's ROE has increased by 37% from the previous quarter and by 8% YoY
Dividends
What is GBIO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GBIO.
Financial health
How did Generation Bio financials performed over time
Generation Bio's total assets is 57% higher than its total liabilities
The quick ratio has soared by 53% from the previous quarter and by 5% YoY
The current ratio has soared by 53% since the previous quarter and by 5% year-on-year
Generation Bio's debt is 19% more than its equity
Generation Bio's debt to equity has surged by 63% YoY and by 9% QoQ
The equity has decreased by 44% YoY and by 15% QoQ
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.